Therapeutic Asset Ratings
4,361 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Carboplatin
Mucinous Adenocarcinoma
National Cancer Institute (NCI)
P3
B
(60)
Carboplatin
Ovarian Clear Cell Malignant Adenofibroma
National Cancer Institute (NCI)
P3
B
(60)
Carboplatin
Ovarian Serous Tumor
National Cancer Institute (NCI)
P3
B
(60)
CARMUSTINE
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)
P3
B
(60)
cc-5013
Light Chain Deposition Disease
National Cancer Institute (NCI)
P3
B
(60)
Ceralasertib
Lung Cancer
National Cancer Institute (NCI)
P3
B
(60)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Hodgkins Lymphoma
National Cancer Institute (NCI)
P3
B
(60)
Cyclophosphamide
T-Cell Childhood Lymphoblastic Lymphoma
National Cancer Institute (NCI)
P3
B
(60)
Cyclophosphamide
Neoplasm
National Cancer Institute (NCI)
P3
B
(60)
Cyclophosphamide
Rhabdomyosarcoma
National Cancer Institute (NCI)
P3
B
(60)
Cytosin-Arabinosid
T-Cell Childhood Lymphoblastic Lymphoma
National Cancer Institute (NCI)
P3
B
(60)
Cytosin-Arabinosid
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)
P3
B
(60)
DARATUMUMAB
Plasma Cell Leukemia
National Cancer Institute (NCI)
P3
B
(60)
Daunorubicin
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
B
(60)
Daunorubicin
T-Cell Childhood Lymphoblastic Lymphoma
National Cancer Institute (NCI)
P3
B
(60)
DEXAMETHASONE
T-Cell Childhood Lymphoblastic Lymphoma
National Cancer Institute (NCI)
P3
B
(60)
Docetaxel
Ovarian Clear Cell Adenocarcinoma
National Cancer Institute (NCI)
P3
B
(60)
Docetaxel
Fallopian Tube Mucinous Adenocarcinoma
National Cancer Institute (NCI)
P3
B
(60)
Docetaxel
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)
P3
B
(60)
Docetaxel
Fallopian Tube Transitional Cell Carcinoma
National Cancer Institute (NCI)
P3
B
(60)
Docetaxel
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P3
B
(60)
Docetaxel
Mucinous Adenocarcinoma
National Cancer Institute (NCI)
P3
B
(60)
Docetaxel
Ovarian Clear Cell Malignant Adenofibroma
National Cancer Institute (NCI)
P3
B
(60)
Docetaxel
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)
P3
B
(60)
Eloxatin
Borderline Epithelial Tumor Of Ovary
National Cancer Institute (NCI)
P3
B
(60)
Showing 651 to 675 of 4,361 assets
Previous
Page 27 of 175
Next